The collaboration will see Sehgal Path Lab rebranded as Neuberg Sehgal Path Lab soon
Neuberg Diagnostics has joined forces with Sehgal Path Lab in a strategic joint venture aimed at enhancing the Haemato-Oncology segment.
The collaboration will see Sehgal Path Lab rebranded as Neuberg Sehgal Path Lab soon.
Dr Kunal Sehgal, a nationally acclaimed haematopathologist, will continue to lead as the Managing Director and Chief Pathologist of the joint venture.
Speaking about the Joint venture, Dr GSK Velu, Chairman and Managing Director, Neuberg Diagnostics said, “I am glad to have joined hands with Dr Kunal Sehgal who is a renowned haematopathologist in India. Through strategic partnerships and continuous innovation, Neuberg Diagnostics aims to deliver unparalleled diagnostic services that positively impact patient outcomes and healthcare delivery. With four entities based in Mumbai and AG Diagnostics, a Neuberg subsidiary, in Pune, Neuberg has significantly bolstered its presence in Maharashtra. This strategic consolidation reaffirms Neuberg’s leadership position in Karnataka, Gujarat, Tamil Nadu, and Madhya Pradesh, while paving the way for further growth and innovation in Maharashtra’s healthcare landscape. Neuberg remains committed to investing in Maharashtra to solidify its position as one of the top diagnostics chains in the state within the next two years”.
Speaking about the Joint venture and the lab, Dr Kunal Sehgal, Managing Director and Chief Pathologist, Neuberg Sehgal Path Lab said, “We are delighted to partner with Neuberg Diagnostics, a global leader in diagnostics innovation. By leveraging Neuberg’s state-of-the-art technologies and Sehgal Path Lab’s trusted reputation, the partnership aims to provide patients with unparalleled access to routine and specialised tests including advanced genetic and oncology services all under one roof. I also look forward to expanding our research and education initiatives, training programs, and collaborations with educational institutions and research organisations to fulfil my vision of developing Haematopathology as a field in the country.”